Review Article
Beyond PSA: Managing Modern Therapeutic Options in Metastatic Castration-Resistant Prostate Cancer
Prostate cancer remains a significant cause of cancer-related deaths in men in the United States. Significant advances in the treatment of metastatic castration-resistant prostate cancer have been made in recent years with the arrival of new therapeutic targets and options. The definition of progression of disease must be thought of…
Posted in:
prostate-specific antigen 3